BACTERIATHROUGHEARLY DETECTIONREDEFINING

BACTERIA ARE THE BEST BIOSENSORS ON EARTH.

SO WE HACKED THEM.

LEARN MORE

DETECT DISEASES EARLIER

BACTERIA AND FUNGI CAN LOCATE CANCER AND OTHER AILMENTS LONG BEFORE A DISEASE BECOMES SYMPTOMATIC OR IS OTHERWISE CAPABLE OF BEING DETECTED BY HUMAN BIOMARKERS. AT GUSTO, WE HAVE DEVELOPED A PROPRIETARY WAY TO USE MICROORGANISMS IN THE BLOOD TO DETECT CANCER AND OTHER DISEASES FASTER AND MORE ACCURATELY THAN EVER BEFORE, OPENING THE WINDOW FOR LIFE-SAVING INTERVENTION.

DETECTION

SUPERCHARGE THE HEALING PROCESS

Our technology allows us to use bacteria to our advantage in order to create the most advanced MICROBIOME THERAPEUTICS in the entire industry. By combining artificial intelligence with bacterial intelligence, Gusto Global’s revolutionary technology has enabled the development of therapeutics that meaningfully and beneficially alter the human microbiome to improve patient outcomes.

THERAPEUTICS

HIGHLIGHTS

OUR RESEARCH

  • The Microbiome as a source of new enterprises and job creation: Considering clinical faecal and synthetic microbiome transplants and therapeutic regulation.

  • Environmental factors, mucosal permeability and defective immunoregulation drive over- active immunity to a subset of resident intestinal bacteria that mediate multiple inflammatory conditions.

  • Due to its fundamental role in the induction, training, and function of the immune system, it is critical to include characterizations of the gut microbiome in clinical trials and studies that aim to broaden our understanding of coronavirus disease 2019 (COVID-19).

NEWS

INDUSTRY UPDATES

  • Cancer-microbe associations have been explored for centuries, but cancer-associated fungi have rarely been examined.

  • New research is revealing that cancer is rife with bacteria and fungi — a rich ecosystem that scientists call the tumor microbiome.

  • Ferring Pharmaceuticals today announced the U.S. Food and Drug Administration (FDA) approved REBYOTAâ„¢ (fecal microbiota, live-jslm).

STRATEGIC
PARTNERS

Questions? We Have Answers.

CONTACT US